PHENYLEPHRINE AND KETOROLAC

PHENYLEPHRINE AND KETOROLAC was reported 82 times

PHENYLEPHRINE AND KETOROLAC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRAM STAIN 1 0.2000
1 FIBRIN 4 0.0930
2 BLEPHAROCHALASIS 2 0.0400
3 CILIARY MUSCLE SPASM 1 0.0294
4 AQUEOUS FIBRIN 1 0.0196
5 TOXIC ANTERIOR SEGMENT SYNDROME 17 0.0156
6 VITREOUS HAZE 2 0.0131
7 ANTERIOR CHAMBER DISORDER 3 0.0130
8 POSTERIOR CAPSULE RUPTURE 1 0.0127
9 RETINAL DRUSEN 2 0.0122
10 PIGMENT DISPERSION SYNDROME 1 0.0105
11 BILIRUBIN URINE PRESENT 1 0.0084
12 ANTERIOR CHAMBER INFLAMMATION 5 0.0084
13 ANTERIOR CHAMBER FIBRIN 1 0.0078
14 BACTERIAL ENDOPHTHALMITIS 2 0.0075
15 CORNEAL OEDEMA 15 0.0067
16 PANOPHTHALMITIS 1 0.0055
17 DRUG EFFECT PROLONGED 3 0.0054
18 HYPOPYON 4 0.0048
19 CORNEAL DEGENERATION 1 0.0041
20 HYPHAEMA 2 0.0038
21 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
22 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
23 ENDOPHTHALMITIS 19 0.0032
24 CORNEAL OPACITY 4 0.0029
25 ANTERIOR CHAMBER CELL 2 0.0028
26 PROCEDURAL HEADACHE 1 0.0024
27 VITRITIS 4 0.0022
28 KERATITIS 4 0.0013
29 IRITIS 4 0.0013
30 PROCEDURAL NAUSEA 1 0.0012
31 VITREOUS OPACITIES 1 0.0012
32 ENDOCRINE OPHTHALMOPATHY 1 0.0012
33 PRODUCT NAME CONFUSION 1 0.0009
34 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
35 PUPIL FIXED 1 0.0006
36 CYSTOID MACULAR OEDEMA 1 0.0005
37 PERIORBITAL SWELLING 3 0.0005
38 EYE CONTUSION 1 0.0005
39 CORNEAL DISORDER 1 0.0005
40 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
41 MEAN CELL VOLUME INCREASED 1 0.0004
42 PRODUCT LABEL CONFUSION 2 0.0003
43 FIBROSIS 1 0.0003
44 IRIDOCYCLITIS 1 0.0003
45 LYMPHOCYTE COUNT INCREASED 1 0.0003
46 PRODUCT PREPARATION ISSUE 2 0.0003
47 DEAFNESS NEUROSENSORY 1 0.0003
48 UVEITIS 4 0.0003
49 PRODUCT LABEL ISSUE 2 0.0003
50 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
51 INTRAOCULAR PRESSURE INCREASED 3 0.0002
52 PHYSICAL DISABILITY 1 0.0002
53 EYE INFLAMMATION 2 0.0002
54 CORONARY ARTERY STENOSIS 1 0.0002
55 CORONARY ARTERIAL STENT INSERTION 1 0.0002
56 VARICOSE VEIN 1 0.0002
57 PRODUCT PACKAGING ISSUE 1 0.0001
58 SINUS BRADYCARDIA 1 0.0001
59 VITREOUS FLOATERS 1 0.0001
60 NEUTROPHIL COUNT INCREASED 1 0.0001
61 VISUAL ACUITY REDUCED 3 0.0001
62 ADRENAL INSUFFICIENCY 1 0.0001
63 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
64 MYDRIASIS 1 0.0001
65 SARS-COV-2 TEST POSITIVE 1 0.0001
66 IMPAIRED QUALITY OF LIFE 1 0.0001
67 CONJUNCTIVITIS 1 0.0001
68 GLAUCOMA 1 0.0001
69 HAEMATOCRIT DECREASED 1 0.0001
70 PRODUCT ADMINISTRATION ERROR 1 0.0000
71 PRODUCT PREPARATION ERROR 1 0.0000
72 GASTRITIS 1 0.0000
73 DRUG ADMINISTRATION ERROR 1 0.0000
74 HYPOTHYROIDISM 1 0.0000
75 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
76 TINNITUS 1 0.0000
77 INFLAMMATION 1 0.0000
78 MEDICATION ERROR 1 0.0000
79 EYE PAIN 1 0.0000
80 DISCOMFORT 1 0.0000
81 VISUAL IMPAIRMENT 2 0.0000
82 SWELLING FACE 1 0.0000
83 THERAPY INTERRUPTED 1 0.0000
84 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
85 BALANCE DISORDER 1 0.0000
86 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
87 ADVERSE DRUG REACTION 1 0.0000
88 ADVERSE EVENT 1 0.0000
89 CARDIAC DISORDER 1 0.0000
90 SWELLING 1 0.0000
91 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
92 HAEMOGLOBIN DECREASED 1 0.0000
93 SEIZURE 1 0.0000
94 EMOTIONAL DISTRESS 1 0.0000
95 PRURITUS 3 0.0000
96 DRY SKIN 1 0.0000
97 HYPOAESTHESIA 1 0.0000
98 BLOOD PRESSURE INCREASED 1 0.0000
99 PARAESTHESIA 1 0.0000
100 CONFUSIONAL STATE 1 0.0000
101 CHEST PAIN 1 0.0000
102 BLOOD GLUCOSE INCREASED 1 0.0000
103 PAIN 3 0.0000
104 WEIGHT DECREASED 1 0.0000
105 ANXIETY 1 0.0000
106 DIZZINESS 1 0.0000
107 DEATH 1 0.0000
108 OFF LABEL USE 1 0.0000
109 DRUG INEFFECTIVE 1 0.0000